Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
03/1998
03/25/1998EP0830347A1 Novel substituted piperazine derivatives having tachykinin receptor antagonists activity
03/25/1998EP0830136A1 New cryptophycins from synthesis
03/25/1998CN1177343A Cell adhesion inhibitors
03/25/1998CN1177299A Certain 1, 4, 5 -tri- substituted imidazole compounds useful as cytokine
03/25/1998CN1176809A Method for preparing traditional Chinese patent medicine for curing asthma
03/25/1998CN1037857C Method for preparing peptide derivatives by using black chain mould
03/24/1998US5731351 Antiarrhythmia agents
03/24/1998US5731350 Substituted benzenedicarboxylic acid diguanides, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
03/24/1998US5731332 Leukotriene antagonists; antiinflammatory agents, antiallergens
03/24/1998US5731321 Endothelin receptor antagonists
03/24/1998US5731309 Asthma
03/24/1998US5731293 Enzyme inhibitors
03/24/1998US5731286 Cyclic neurokinin A antagonists
03/19/1998WO1998011236A1 Aspartic protease
03/19/1998WO1998011128A1 Modified aminoacids, pharmaceuticals containing these compounds and method for their production
03/19/1998WO1998011119A1 Novel pyranoside derivatives
03/19/1998WO1998011095A1 Substituted 2-pyrimidineamines, their preparation and their use as proteine kinase inhibitors
03/19/1998WO1998011062A1 Benzamidine derivatives and the use thereof as medicaments with ltb4-antagonistic effect
03/19/1998WO1998011049A1 Lipoxin compounds and their use in treating cell proliferative disorders
03/19/1998WO1998010796A1 Compositions and methods for pulmonary gene delivery
03/19/1998WO1998010652A1 NOVEL trpS
03/19/1998DE19637123A1 Neue Pyranosidderivate New Pyranosidderivate
03/19/1998CA2265838A1 Compositions and methods for pulmonary gene delivery
03/19/1998CA2264541A1 Human protein kinases
03/19/1998CA2262818A1 Modified amino acids, pharmaceuticals containing these compounds and methods for their production
03/18/1998EP0828833A1 Chemokine n-terminal deletion mutations
03/18/1998EP0828742A1 Diazepino-indoles as phosphodiesterase iv inhibitors
03/18/1998EP0828733A1 Benzopyrans and pharmaceutical compositions containing them
03/18/1998EP0828730A1 Piperazine derivatives
03/18/1998EP0828712A1 Beta-adrenergic agonists
03/18/1998EP0828493A1 4.4-(disubstituted)cyclohexan-1-ols-monomers and related compounds
03/18/1998CN1176648A A method of identifying CFTR-binding compounds useful for activating chloride conductance in animal cells
03/18/1998CN1176599A Pharmaceutical composition for piperidinoalkanol compounds
03/18/1998CN1176118A Chinese medicine for tracheitis
03/18/1998CN1176115A Asthma curing plaster
03/18/1998CN1037773C Heteroatoms-containing tricyclic compounds
03/17/1998US5728844 Immunotherapeutic agents
03/17/1998US5728738 Mixing alkali with sodium mercaptoethylsulfonate
03/17/1998US5728716 Trachykinin peptide for nervous system disorders and cardiovascular disorders
03/17/1998US5728702 Bronchodilator agents, antiallergens or antiplatelet druggs
03/17/1998US5728686 Alkylxanthine phosphonates and alkylxanthine phosphine oxides and their use as pharmaceuticals
03/17/1998CA1339724C Anti-inflammatory factor, method of isolation, and use
03/12/1998WO1998009985A2 Anti-inflammatory peptides and uses thereof
03/12/1998WO1998009977A1 Tetrahydronapthalene derivatives and their therapeutic use
03/12/1998WO1998009970A2 Alkylated rapamycin derivatives
03/12/1998WO1998009969A1 Novel aryl-pyridazines
03/12/1998WO1998009961A1 Indazole derivatives and their use as inhibitors of phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf)
03/12/1998WO1998009949A1 Novel acetamide derivatives and protease inhibitors
03/12/1998WO1998009946A1 N-substituted indol-3-glyoxylamid with antiasthmatic, antiallergic and immunosuppressive/immunomodulating effect
03/12/1998WO1998009630A1 Compounds and methods
03/12/1998WO1998009626A1 Methods for in vivo reduction of iron levels and compositions useful therefor
03/12/1998WO1998009625A1 SELECTIVE β3 ADRENERGIC AGONISTS
03/12/1998WO1997041895A3 TREATMENT OF ASTHMA WITH TNFR-Ig
03/12/1998DE19636689A1 Neue Benzamidinderivate New benzamidine derivatives
03/12/1998DE19636150A1 N-substituierte Indol-3-glyoxylamide mit antiasthmatischer, antiallergischer und immunsuppressiver/immunmodulierender Wirkung N-substituted indole-3-glyoxylamides with anti-asthmatic, anti-allergic and immunosuppressive / immunomodulatory effect
03/12/1998CA2592537A1 Nitric ester derivatives in the treatment of inflammatory diseases
03/12/1998CA2266039A1 Alkylated rapamycin derivatives
03/12/1998CA2264942A1 Compounds and methods
03/12/1998CA2264798A1 Indazole derivatives and their use as inhibitors of phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf)
03/12/1998CA2264737A1 Tetrahydronaphthalene derivatives and their therapeutic use
03/12/1998CA2264285A1 Anti-inflammatory peptides and uses thereof
03/12/1998CA2263686A1 Methods for in vivo reduction of iron levels and compositions useful therefor
03/12/1998CA2263586A1 Novel aryl-pyridazines
03/12/1998CA2263198A1 Novel acetamide derivatives and protease inhibitors
03/11/1998EP0827746A1 Carbazole analogues as selective B3 adrenergic agonists
03/11/1998EP0827400A2 Use of a pharmaceutically acceptable oxalate derivative in the manufacture of a medicament for the treatment of skin conditions
03/11/1998EP0666757B1 Anti-inflammatory, tolerogenic and immunostimulatory properties of carbohydrate binding-proteins
03/11/1998EP0663902B1 25-carboxylic acid derivatives in the vitamin d series, pharmaceutical preparations containing these derivatives and their use in the manufacture of medicines
03/11/1998CN1175944A 1 -aryl -2 -acylamino-ethane compounds and their use as neurokinin especially neurokinin 1 antagonists
03/11/1998CN1175903A Method of treating adenosine depletion
03/10/1998US5726305 Substituted quinoline-2-carboxamides, their preparation and their use as pharmaceuticals, and intermediates
03/10/1998US5726194 Endothelin receptor antagonists
03/10/1998US5726160 Treatment of diseases such as cystic fibrosis, emphysema, bronchitis and sinusitis
03/10/1998US5726158 Peptide derivatives
03/10/1998US5726156 Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels
03/05/1998WO1998008850A1 Spirocyclic metalloprotease inhibitors
03/05/1998WO1998008847A1 Substituted 6,5-hetero-bicyclic derivatives
03/05/1998WO1998008841A1 New thiazole derivatives with phosphodiesterase-inhibiting effect
03/05/1998WO1998008827A1 Heterocyclic metalloprotease inhibitors
03/05/1998WO1998008826A1 Piperazino derivatives as neurokinin antagonists
03/05/1998WO1998008825A1 1,4-heterocyclic metalloprotease inhibitors
03/05/1998WO1998008823A1 Heterocyclic metalloprotease inhibitors
03/05/1998WO1998008822A1 1,3-diheterocyclic metalloprotease inhibitors
03/05/1998WO1998008545A1 Methods for treating disorders by using interleukin-9 and its antagonists
03/05/1998WO1998008523A1 Hydrogenous medicament
03/05/1998WO1998008519A1 Chlorofluorocarbon-free mometasone furoate aerosol formulations
03/05/1998WO1998001554A3 Secreted proteins and polynucleotides encoding them
03/05/1998CA2264266A1 1,3-diheterocyclic metalloprotease inhibitors
03/05/1998CA2264045A1 Heterocyclic metalloprotease inhibitors
03/05/1998CA2264044A1 Spirocyclic metalloprotease inhibitors
03/05/1998CA2263935A1 Methods for treating disorders by using interleukin-9 and its antagonists
03/05/1998CA2263932A1 1,4-heterocyclic metalloprotease inhibitors
03/05/1998CA2263917A1 Heterocyclic metalloprotease inhibitors
03/04/1998EP0826774A2 Staphylococcal Fab I enoyl-ACP reductase
03/04/1998EP0825993A1 Xanthines and their therapeutic use
03/04/1998EP0825991A1 Diaryldiamine derivatives and their use as delta opioid (ant)-agonists
03/04/1998EP0825885A1 Pulmonary delivery of aerosolized medicaments
03/04/1998EP0616523B1 Medicaments
03/04/1998CN1175263A Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders
03/04/1998CN1175260A Induction of cytotoxic t -lymphocyte responses
1 ... 791 792 793 794 795 796 797 798 799 800 801 802 803 804 805 806 807 808 809 810 811 ... 878